T3-T4期头颈癌的早期死亡:NCDB中手术与非手术方法的比较
该研究基于美国国家癌症数据库(NCDB)2004至2018年数据,回顾性分析79 677例T3-T4期头颈鳞状细胞癌(HNSCC)患者,比较原发手术(PS)与放疗联合或不联合化疗(CRT)的30天死亡率。PS组早期死亡率为1.1%,CRT组为4.7%(p < 0.001),校正混杂因素后PS相比CRT的早期死亡OR为0.25(95% CI 0.22-0.28)。亚组分析显示无论HPV状态如何,PS均与生存获益相关。
要点
- T3-T4期HNSCC原发手术组早期死亡率为1.1%,CRT组为4.7%(p < 0.001)。
- 校正年龄、合并症指数、III或IV期、亚部位、保险状态和分级后,PS相比CRT的早期死亡OR为0.25(95% CI 0.22-0.28)。
- 年龄≥65岁、T4肿瘤、较高Charlson合并症指数(CCI)和无保险状态与死亡风险增加相关。
核心结论
- 本研究提示,对于HNSCC, upfront手术方法与非手术治疗相比与早期死亡减少相关。
- 基于HPV的亚组分析显示了更聚焦的早期死亡预测因素。
- 癌症治疗范式应考虑这些发现对晚期HNSCC的观察。
研究设计与样本
- 本研究为回顾性分析,使用美国国家癌症数据库(NCDB)v2018数据,纳入2004年至2018年T3-T4期HNSCC患者。
- 共纳入79 677例晚期头颈癌患者,平均(SD)年龄62.5(12.0)岁,以男性为主(74.0%)。
- 采用单变量和多变量逻辑回归分析,主要目标是比较原发手术(PS)与放疗联合或不联合化疗(CRT)患者的30天死亡率。
- 按HPV状态进行治疗组间亚组分析。
主要发现
- T3-T4期HNSCC接受 upfront手术的患者早期死亡率为1.1%,而CRT组为4.7%(p < 0.001)。
- 校正年龄、合并症指数、III或IV期、亚部位、保险状态和分级后,PS相比CRT的早期死亡OR为0.25(95% CI 0.22-0.28)。
- 亚组分析显示,无论HPV状态如何,PS均与生存获益相关。
- 年龄≥65岁、T4肿瘤、较高Charlson合并症指数(CCI)和无保险状态与死亡风险增加持续相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgeries for T3-T4 head and neck squamous cell carcinoma (HNSCC) are often complex and high-risk with the potential for early death, which is both clinically devastating and a negative quality indicator for health systems. This study aims to compare surgical and non-surgical approaches in an aggressive subset of HNSCC for early death. METHODS: This is a retrospective analysis of the National Cancer Database (NCDB) v2018 for advanced T3-T4 HNSCC patients from 2004 to 2018. Univariate and multivariate logistic regression analyses were performed with the primary goal of comparing 30-day mortality in patients undergoing primary surgery (PS) versus radiation with or without chemotherapy (CRT). Subgroup analysis between treatment groups was performed with respect to HPV status. RESULTS: A total of 79 677 advanced head and neck cancer patients with a mean (SD) age of 62.5 (12.0) years, predominantly male (74.0%), were included in the analysis. Patients with T3-T4 HNSCC undergoing upfront surgery had an early death rate of 1.1%, compared to 4.7% for CRT (p < 0.001). This translated to significantly lower odds of early death with PS compared to CRT (OR = 0.25, 95% CI 0.22-0.28), adjusting for age, comorbidity index, stage III or IV, subsite, insurance status, and grade. Subset analysis showed survival benefits of PS irrespective of HPV status. Age ≥ 65 years, T4 tumors, higher Charlson Comorbidity Index (CCI), and uninsured status were consistently associated with increased mortality risk. CONCLUSION: This study suggests that an upfront surgical approach is associated with decreased early death compared to non-surgical treatment for HNSCC. HPV-based subgroup analysis has shown a more focused predictor of early death. Cancer treatment paradigms should account for the observation of these findings for advanced HNSCC.
引用
- Vasudevan SS, Alvarez IA, Nathan CO, et al. Early Death in T3-T4 Head and Neck Cancer: NCDB Comparison of Surgical vs. Non-Surgical Approaches. Head Neck. 2025. PMID: 40384552. doi:10.1002/hed.28193
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。